⌘K
Loading ticker…
As of 2026-08-24, Gossamer Bio, Inc. Common Stock (GOSS) has a 3-month relative strength percentile of 23 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 31. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 12.5%, relative volume 0.99×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
GOSS is held by 14 ETFs as of May 2026. Top owner: SCHA at 0.00% weight, $228K notional. Top 3 carry $579K.
Held by 27 ETFs · $8M across latest filings · largest weight 0.12% (IWC).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| SCHASchwab U.S. Small-Cap ETF | 0.00% | $228K | — |
| VTWO | 0.00% | $226K | — |
| VHTVanguard Health Care ETF | 0.00% | $125K | — |
| VTWG | 0.00% | $42K | — |
| OMFS | 0.00% | $13K | — |
| VTHRVanguard Russell 3000 ETF | 0.00% | $4K | — |
| IBBQ | 0.00% | $3K | — |
| ITWO | 0.00% | $2K | — |
| BIB | 0.00% | $2K | — |
| MSSM | 0.00% | $2K | — |
Showing 10 of 14 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | GOSS Jan avg: -0.73% median: 0.95% win: 50% σ: 21.03% n: 4 2022-04-12 → 2026-07-31 | GOSS Feb avg: -6.05% median: -5.34% win: 50% σ: 65.40% n: 4 2022-04-12 → 2026-07-31 | GOSS Mar avg: -19.18% median: -19.50% win: 0% σ: 7.27% n: 4 2022-04-12 → 2026-07-31 | GOSS Apr avg: -11.91% median: -7.27% win: 40% σ: 21.20% n: 5 2022-04-12 → 2026-07-31 | GOSS May avg: -7.88% median: 2.03% win: 60% σ: 19.09% n: 5 2022-04-12 → 2026-07-31 | GOSS Jun avg: 8.61% median: 10.81% win: 60% σ: 30.85% n: 5 2022-04-12 → 2026-07-31 | GOSS Jul avg: 23.15% median: 12.50% win: 100% σ: 27.34% n: 5 2022-04-12 → 2026-07-31 | GOSS Aug avg: 4.88% median: 9.13% win: 50% σ: 22.14% n: 4 2022-04-12 → 2026-07-31 (current) | GOSS Sep avg: -3.80% median: -3.82% win: 50% σ: 15.64% n: 4 2022-04-12 → 2026-07-31 | GOSS Oct avg: -16.29% median: -9.17% win: 0% σ: 15.89% n: 4 2022-04-12 → 2026-07-31 | GOSS Nov avg: 12.35% median: 7.92% win: 50% σ: 40.16% n: 4 2022-04-12 → 2026-07-31 | GOSS Dec avg: -8.90% median: 4.74% win: 50% σ: 46.40% n: 4 2022-04-12 → 2026-07-31 |